14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
HFBL vs CBAN: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Home Federal Bancorp, Inc. of Louisiana (HFBL) captures the overall head-to-head institutional edge over Colony Bankcorp Inc. (CBAN) on higher Unified Composite conviction (61.3/100 BUY vs. 44.9/100 HOLD) after splitting the core matrix 5–5 (led by Profitability & Quality), while CBAN wins 4–1 across the 6-pillar growth and valuation breakdown. HFBL trades at $24.19 (11.8x Forward P/E, 37.1% operating margin) versus CBAN at $20.18 (8.4x Forward P/E, 33.4% operating margin).
Growth vs. Quality Trade-Off: HFBL earns the overall head-to-head edge with a stronger Unified Composite Score (61.3/100 BUY vs. CBAN 44.9/100 HOLD) and 0.00β · 81% Vol risk profile, whereas CBAN leads top-line expansion (+26.0% YoY revenue growth, 2.11x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: HFBL trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 54.4); meanwhile CBAN is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HFBL vs CBAN. Trailing 12-month operating profitability (HFBL 37.1% vs CBAN 33.4%) and valuation multiples (HFBL 11.8x vs CBAN 8.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Banks - Regional value chain with $71.8M market capitalization and 37.1% operating margin.
OpEx & R&D Reinvestment62.9% of Rev ($15M)
90D Engineering Disclosures0 Published
CBAN Moat ProfileHigh-Margin Pricing Power Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $555.2M market capitalization and 33.4% operating margin.
OpEx & R&D Reinvestment66.6% of Rev ($102M)
90D Engineering Disclosures0 Published
Investor FAQ HFBL vs CBAN Key Questions & Quantitative Answers
As of Nov 16, 2026, Home Federal Bancorp, Inc. of Louisiana (HFBL) captures the overall head-to-head institutional edge over Colony Bankcorp Inc. (CBAN) on higher Unified Composite conviction (61.3/100 BUY vs. 44.9/100 HOLD) after splitting the core matrix 5–5 (led by Profitability & Quality), while CBAN wins 4–1 across the 6-pillar growth and valuation breakdown. HFBL trades at $24.19 (11.8x Forward P/E, 37.1% operating margin) versus CBAN at $20.18 (8.4x Forward P/E, 33.4% operating margin). Growth vs. Quality Trade-Off: HFBL earns the overall head-to-head edge with a stronger Unified Composite Score (61.3/100 BUY vs. CBAN 44.9/100 HOLD) and 0.00β · 81% Vol risk profile, whereas CBAN leads top-line expansion (+26.0% YoY revenue growth, 2.11x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: HFBL trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 54.4); meanwhile CBAN is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CBAN leads the Growth & Scale pillar: HFBL posts +10.5% YoY revenue growth and +19.2% YoY earnings growth on $24M TTM revenue (100.0% gross margin, 37.1% operating margin), compared with CBAN at +26.0% YoY revenue growth and +50.2% YoY earnings growth on $154M TTM revenue (100.0% gross margin, 33.4% operating margin). On trailing 12-month operating scale, HFBL generates $24M in USD-normalized revenue versus $154M for CBAN. In operating R&D and SG&A reinvestment, HFBL deploys 62.9% of Rev ($15M) (0 90-day corporate R&D disclosures) versus 66.6% of Rev ($102M) (0 disclosures) for CBAN.
CBAN screens cheaper on headline valuation multiples. HFBL trades at 11.8x Forward P/E, 11.3x Trailing P/E, N/M PEG, and 2.9x EV/Revenue (unreported cash flow margin), whereas CBAN trades at 8.4x Forward P/E, 11.2x Trailing P/E, 2.11x PEG, and 3.6x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HFBL (11.2% ROE) versus CBAN (10.8% ROE) capital efficiency.
In options market volatility and institutional positioning, HFBL carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.00β · 81% Vol realized risk). By comparison, CBAN carries 594.7% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.37β · 20% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.